GLP-1 Weight Loss Drugs and Their Impact on Value-Based Care
A New Interactive Webinar
Wednesday, October 11 — 1:00-2:30PM Eastern/10:00-11:30AM Pacific

MODESTO, CA USA -- HEALTHCARE UPDATE NEWS SERVICE -- SEPTEMBER 25, 2023: A group of drugs known as glucagon-like peptides 1 (GLP-1) were originally developed to better manage diabetes. But GLP-1 drugs such as Ozempic, Mounjaro and Wegovy have more recently been used to combat obesity, with some users reporting weight loss of 60 pounds or more that remains permanent so long as they continue taking the medication.

A new study released by the manufacturer of Wegovy also concluded that using the drug for weight loss reduces the risk of serious cardiovascular episodes by about 20%. Manufacturers are also formulating new GLP-1s that may be even more effective in achieving dramatic and permanent weight loss.

That begs the question: Will these drugs play a role in value-based care for patients with chronic conditions such as obesity, or will the cost of GLP-1s take such a proposition off the table?

Please join us on Wednesday, October 11, 2023 for a 90-minute webinar as a panel of distinguished experts discusses the potential future role of GLP-1 weight loss drugs in delivering value-based care. Specific topics that will be covered:

  • What are GLP-1 drugs and how do they work?
  • The GLP-1 price/cost curve
  • The impact of GLP-1 on the health of patients/users
  • Who is being prescribed GLP-1 drugs?
  • How GLP-1s have been contributing to overall healthcare costs in the U.S.
  • Will GLP-1 drugs impact the volumes of bariatric surgery?
  • Employer, payer and provider opinions and responses to the use of GLP-1s for weight control
  • What the future holds for GLP-1 drugs and value-based cared

You'll also be able to ask the speakers your situation-specific questions, and hear their solutions for your challenges PLUS those of your colleagues. And because this is a webinar, there is no limit to the number of people you can invite to join you at your workplace.

P.S. Your satisfaction is unconditionally guaranteed. Your goal is patient satisfaction — our goal is yours. If, after attending, you decide this webinar has failed to meet your needs, we will IMMEDIATELY reimburse you for your tuition. You have my word.

P.P.S. If you'd like to invite multiple sites to join you for this session, email ( for special discount pricing.


For changes or additions, please email your request to: listmgr@HealthcareUpdateNewsService.

For removal of your e-mail address, please click the "SafeUnsubscribe" link located in the footer of this message below to automatically remove your address from the list.